The viral and host genomic landscape of human T-cell leukemia virus type I in Peru.
Understanding why one Peruvian population faces extreme leukemia risk reveals genetic patterns that could guide better screening and care strategies for affected communities.
This first-of-its-kind genomic study of HTLV-1 in Peru found exceptionally high proviral loads, early oncogenic mutations in cancer genes, and reduced immune diversity in an underserved population with the world's highest ATLL incidence. These findings reveal population-specific risk features and support tailored surveillance approaches.
What the study was
- Study design
- Prospective cohort with integrated genomics
- Population
- HTLV-1-infected individuals in Lima, Peru — highest global ATLL incidence region
- Sample size
- 67
- Category
- Genomics/Precision Medicine
- Maturity
- Validated
- Journal
- Virology journal
Why it surfaced
First comprehensive HTLV-1 genomic characterization in South America with novel findings on early oncogenic transformation in underserved population. High unmet need and health equity relevance.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.